STATCenter·
STAT+: FDA warns GLP-1 drugs carry potential risk of rare eye condition
The FDA on Monday warned that GLP-1 drugs carry a potential risk for a rare but serious eye condition that's sometimes referred to as an "eye stroke."
Read at STAT →
Health · 1 sources covering this
STAT+: FDA warns GLP-1 drugs carry potential risk of rare eye condition
The FDA on Monday warned that GLP-1 drugs carry a potential risk for a rare but serious eye condition that's sometimes referred to as an "eye stroke."
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/45bf234b34d663be03042eeb595b38bf14907c88" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: FDA warns GLP-1 drugs carry potential risk of rare eye condition"></iframe>
